UnitedHealth Group Incorporated (NYSE:UNH) had its target price raised by Deutsche Bank AG from $187.00 to $197.00 in a report published on Thursday, July 13th. The brokerage currently has a buy rating on the healthcare conglomerate’s stock.
A number of other research analysts have also recently commented on the company. Credit Suisse Group reissued an outperform rating and issued a $200.00 price target (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Sanford C. Bernstein reissued an outperform rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. BidaskClub raised UnitedHealth Group from a buy rating to a strong-buy rating in a report on Saturday, July 8th. Cantor Fitzgerald reissued a buy rating and issued a $205.00 price target on shares of UnitedHealth Group in a report on Friday, July 7th. Finally, Stifel Nicolaus reissued a buy rating and issued a $185.00 price target on shares of UnitedHealth Group in a report on Wednesday, June 28th. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus price target of $202.20.
Shares of UnitedHealth Group (UNH) traded up 0.23% during midday trading on Thursday, hitting $193.02. 2,210,720 shares of the stock were exchanged. The firm’s 50 day moving average price is $189.18 and its 200-day moving average price is $174.51. The stock has a market cap of $186.62 billion, a P/E ratio of 23.19 and a beta of 0.64. UnitedHealth Group has a 52-week low of $132.39 and a 52-week high of $196.04.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the previous year, the firm earned $1.96 EPS. The business’s quarterly revenue was up 7.7% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group will post $9.87 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Deutsche Bank AG Raises UnitedHealth Group Incorporated (UNH) Price Target to $197.00” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2017/08/11/unitedhealth-group-incorporated-unh-pt-raised-to-197-00-at-deutsche-bank-ag-updated-updated-updated.html.
In related news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the sale, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock worth $2,873,320 in the last ninety days. 0.89% of the stock is currently owned by corporate insiders.
Several large investors have recently modified their holdings of UNH. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the second quarter worth $110,000. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth $114,000. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth $121,000. Hedge funds and other institutional investors own 86.37% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.